Collects public and private clinical studies of human volunteers in about 200 countries. ClinicalTrials.gov contains data self-reported by trial sponsors or investigators by means of a Web-based system. The database provides information about studies protocols and also some informations about the study results.
Gathers clinical trials about amyotrophic lateral sclerosis (ALS). PRO-ACT is a public database which compiles datasets from industry and academic clinical trials according to a comprehensive common data structure with the aim of easing research about ALS. It includes more than 10700 demographics data and over 68000 longitudinal information on revised ALS Functional Rating Scale (ALSFRS(-R). Information about vital capacity, vital signs, safety labs, concomitant medications and adverse events are also provided.
Provides information about active pharmaceutical ingredients with evidence of clinical testing. CDEK is a public platform for analyzing all active pharmaceutical ingredients that have ever been tested in humans and their sponsoring organizations and those participating in pre-approval clinical activities. This resource supports the investigation of several aspects of drug development, including discovery, repurposing opportunities, chemo- and bio-informatics, clinical and translational research, and regulatory sciences.
Consists of a database on novel cancer drugs and therapeutic products approved by the US Food and Drug Administration (FDA) between 2000 and 2016. CEIT-Cancer describes and characterizes information on the clinical trial evidence of novel cancer drugs at the time of their approval by the FDA. This database allows systematic analysis and assessment of early evidence on the benefits and harms of novel drug treatments and provides a basis for continuous meta-epidemiological analyses.
Works on making clinical trial data from the FDA (US Food and Drug Administration) more easily accessible and searchable. OpenTrialsFDA extracts the relevant data from the FDA documents, link it to other clinical trial data and present it through this new user-friendly web interface. Through the OpenTrialsFDA interface, users are able to explore and discover the FDA data. In addition, the information has been integrated into the OpenTrials database, so that the FDA report can be linked to reports from other sources, such as ClinicalTrials.gov, EU CTR, HRA, WHO ICTRP, and PubMed.
You can access more results by creating a free plan account or unlimited content via a premium account.